|
ANTX An2 Therapeutics Inc 1880438 |
| Balance Sheet |
|
Current Assets
|
97,689,000 |
|
Assets
|
97,689,000 |
|
Current Liabilities
|
10,017,000 |
|
Liabilities
|
10,017,000 |
|
Equity
|
87,672,000 |
|
Shares Out
|
29,842,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-43,984,000 |
|
Investing Cash Flow
|
61,469,000 |
| Market Analysis |
Market Cap
|
31,334,550 |
|
Price
|
1.45 |
|
BVPS
|
2.94 |
|
PB
|
0.49 |
|
EPS
|
-2.26 |
|
PS
|
1.40 |
|
FCF
|
17,485,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ANTX documents filed with the SEC.
ANTX Filings
Clear
